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Abstract
Background: Controversy still exists in the indication and timing of surgical treatment of
pulmonary hamartoma (PH). The objective of this study is to summarize the experience and the
outcome of the surgical treatment for pulmonary hamartomas, and to assess the effectiveness and
necessity of surgical therapy administered in patients with pulmonary hamatoma as well as clinical
and pathological features and long-term follow-up results.
Methods: This retrospective report has reviewed a 20-years clinical history of surgical treatment
for 39 patients with PH from 1985 to 2006. These thirty-nine patients underwent 40 operations as
follows: wedge resection (23), enucleation (10), segmentectomy (3), lobectomy (3), and
pneumonectomy (1).
Results: The PH occurred most frequently (78.1%) in the patients aged 40 to 60 years and the sex
ratio (male/female) was 2.25/1 in our series. No postoperative death was encountered. One patient
with pleural effusion was cured after thoracentesis. All of these 39 patients were proved with
pathologic diagnosis of PH and the popcorn calcification was found in 6 cases before operation. In
38 cases having the mean follow-up of 7.3 years, a patient was operated thrice for regional
recurrence.
Conclusion: Fast frozen section in operation is critical for acquire accurate pathological diagnosis.
Due to potential trend of recurrence or malignance, patients with hamartoma should be submitted
to a complete evaluation and a regular follow-up.
Background
The incidence of pulmonary hamartoma (PH) in the gen-
eral population was 0.25% [1]. In the patients with
benign tumor of the lung, hamartoma was the most com-
mon and accounting for 3% of all tumors of lung [2], and
6% of solitary pulmonary nodules [3]. According to the
autopsy results from the Mayo Clinic, PHs were found in
2 of 7, 972 cases (0.025%) [4]. Another large autopsy
series study from South Africa displayed that PHs were
found in 152 of 47, 635 male coal miners (0.32%) [5]. PH
was usually composed of a mixture of cartilage, fat,
fibrous tissue, and smooth muscle and of branching clefts
of nonneoplastic reactive bronchial-type epithelium.
Actually, the word "hamartoma" deriving from Greek
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Albrecht [7] in 1904 to describe lesions that contained an
abnormal mixture of normal components of an organ [6-
8]. PH was thought to arise from embryologic rests that
were present in fetal life but generally did not become vis-
ible until adulthood. But a cytogenetic analysis of the PHs
showed an abnormal karyotype and revealed recombina-
tions between chromosomal bands 6p21 and 14q24 [9],
thus supporting the opinion that a hamartoma of the lung
was a true neoplasm. However, the nosogenesis of PH
remains unclear. Most clinical studies about PH focused
on the difference to malignant lesions and the diagnosis
measures with effectiveness and specificity. Today, even
with the advancement in medical therapy, pulmonary
resection remains the most important measure of treat-
ment of patient with hamartoma of lung. Controversy,
however, still exists about the indication and timing of
surgery [10-12], and the incidence of malignance or recur-
rence occurred postoperatively is still under question
[13,14]. Herein we analyzed a 20-year historical series of
patients with PHs who underwent surgical resection in
our hospital, and assessed the effectiveness and necessity
of surgical therapy administered in patients with PH as
well as clinical and pathological features and long-term
follow-up results.
Methods
From January 1985 to December 2006, 39 consecutive
patients with PH underwent surgical resection in the
Department of Thoracic Surgery, Daping Hospital. The
medical records of these patients were reviewed before
surgery. The information about the age and gender of
patients, course of disease, initial manifestations or symp-
toms, history of tobacco consumption, calcification in the
hamartoma, location and size of the lesions, operative
procedures, surgical complication, hospital stay after
tumor resection and outcome was recorded. Intraopera-
tive frozen section examination was performed in 32 of
these patients (82.1%) and the histological diagnosis was
obtained postoperatively from the resected specimen. To
reconfirm the diagnosis of PH, the same pathologist
reviewed all available histological slides. All patients had
clinical follow-up by the same team of surgeons. Stable
clinical outcome was also confirmed by telephoning the
patients. The mean follow-up was 7.3 years (range: 1.5–14
years). Numerical data were presented as the mean ± SD.
The difference between means was performed with
ANOVA. All statistical analyses were performed using
SPSS11.0 software (Chicago, IL, USA) and p < 0.05 was
considered as statistically significant
Results
In our series, 27 (69.2%) patients were male and the sex
ratio (male/female) was 2.25/1. There was significant dif-
ference in sex ratio between male and female patients (P <
0.05). The mean age at surgery was 48.9 ± 13 years (range:
25–69 years). Twenty-eight of the patients (71.8%) were
between 40~60 years and only one patient (3.2%) was
under 30 (25 years old). Significant difference was also
observed in different age group (P < 0.01) (shown in
Table 1). And PH occurred most frequently (71.8%) in the
patients aged from 40 to 60 years in our series. The course
of disease ranged from 0.5 month to 6 years (mean of 1.56
years). Thirty (76.9%) of our patients had chest symptoms
such as coughing, expectoration and thoracalgia. In these
30 patients, hemoptysis was encountered in 4 cases
(10.1%), pyrexia in 4 (10.1%), and hypodynamia in 3
cases (7.7%). The remaining 9 patients (23.1%) were
asymptomatic at the time of diagnosis (shown in Table 1).
No respiratory infection or obstructive pneumonia due to
obstruction of the bronchus was encountered in our
series. One patient had accepted gastric myomatectomy
before admission, one had the history of thoracic injury,
and one had multiple renal cysts. Chest X-rays examina-
tion was performed preoperatively in all cases, the most
common manifestation of chest roentgenogram was an
irregular high-density margin with small lobulations
located peripherally. In terms of the location of lesion,
there was no significant difference between the right and
left lung (P > 0.05). The mean diameter of tumors was 2.9
± 1.6 cm (range: 1.5 – 8.5 cm). Most of the PHs in our
series (53.8%) had the diameter ranged from 2.0 to 3.0
cm, 13 of them (33.4%) were under 2.0 cm and only 5
(12.8%) over 3.0 cm (shown in Table 2). Calcification for-
mation was found in 15 cases (38.5%), only 6 of them
(15.4%) were the typical popcorn calcification, and the
remaining 9 (23.1%) had patching calcification on chest
roentgenogram. Chest computed tomography performed
by radiology department in our hospital was obtained in
17 patients, and the other 19 patients accepted CT exami-
nation at other hospitals. So there were 36 patients had CT
scan. Due to financial reasons, the remaining 3 patients
didn't accept this expensive examination.
In all of these patients in our series, there were 38 cases
accepted 38 operations, including 23 wedge resections (4
cases had video-assisted thoracoscopic surgery), 10 tumor
enucleations, 3 segmentectomies and 2 lobotomy. The
remaining one patient accepted tumor enucleation in
local hospital at age of 25 years, the tumor located in
upper lobe of right lung with pathological diagnosis of
chondromatous hamartoma. Regional recurrence was
found and resection of tumor was performed twice in 9
years after the first operation. The patient underwent
tumor enucleation and right upper lobectomy respec-
tively. However, similar lesion occurred again at the ipso-
lateral lung after the third surgical treatment. Because of
three enormous tumors (with diameter over 8.0 cm) occu-
pying the remaining middle and lower lobe of right lung,
a pneumonectomy had to be performed. Moreover,Page 2 of 5
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coagulation, the intraoperative hemorrhage was hard to
control. The total amount of blood transfusion was 14,
700 ml (including 3, 900 ml banked blood and 10, 800
ml of reclaimed blood). Fortunately, this patient recov-
ered smoothly after operation without any complication.
No patient died in the postoperative period or during the
follow-up period. Postoperative pulmonary atelectasis
occurred in one patient at the operation day, and the
blood coagulum obstructing the right principal bronchus
was found by emergent bronchofibroscope examination.
After removing the clot, the breath sound of right lung
recovered. Due to inadequate drainage, pleural effussion
was encountered in one patient and was cured by thora-
centesis. Follow-up continued until March 2007, ensuring
a minimal follow-up of one and a half years. Thirty-eight
patients submitted the regular follow-up, but one patient
lost touch after discharging. The mean follow-up was 7.3
years (range: 1.5–14 years). Recurrent disease developed
three times in one patient (2.6%) after enucleating of the
tumor. At the end of follow-up, none of the 38 patients
died, and the concomitant malignant lesion was not
found in our series after operation.
Discussion
PH occurs most frequently in the patients aged from 40 to
70 years, with a variation in male preponderance from 2:
1 to 4: 1 [4,15], this maybe due to the higher morbility of
pulmonary disease in male. In our series, the ratio was
2.25: 1, and 21 patients (53.8%) had heavy smoking his-
tory. Twenty-eight of our patients (71.8%) were between
40~60 years and only one patient was under 30 (25 years
old), which was consistent with other studies. PH could
occur in all parts of lung, but most often in the periphery
and rarely near the hilar parts [16,17]. Endobronchial
hamartoma was reported in approximately 3% to 19.5%
cases [10,17-19], but not been found in our series.
Hamartomas are usually solitary, well-demarcated nod-
ules on roentgenogram. Multiple hamartoma are a rare
entity and only 19 cases have been described in the world
[20-22]. Slow growth is the norm for PH, malignancy is
rare and only rare cases have been reported [23,24]. PHs
are predominantly composed of cartilage; other compo-
nents include fibromyxoid connective tissue, fat, bone
and smooth muscle [25]. Usually, the PH has non-specific
clinical manifestations and was detected by chest radio-
graphic examination occasionally [4,11,16,25]. The respi-
ratory infection or pulmonary atelectasis due to
mechanical obstruction of the bronchus could be encoun-
tered in part of patients with PH. In our series, part of
patients (23.1%) were asymptomatic at the time of diag-
nosis, and which supported the concept that clinical man-
ifestation could not be the effective method or standard of
the diagnosis for PH.
Although hamartoma was generally considered to be a
benign neoplasm, there have been several reports of
increased risk to lung cancer in patients with a chondrom-
atous hamartoma and the relationship between hamar-
toma and the synchronous malignancy was still unclear
[23,26,27]. Tomiyasu et al [28] reported a unique hamar-
toma that penetrated the visceral pleura, and after surgical
resection, a new bronchial carcinoma had arisen at the
same site. Kato and his colleagues found a postoperative
recurrence in a patient with multiple pulmonary leiomy-
matous hamartoma [29]. Moreover, similar recurrence of
PH was also encountered in our study. A male case under-
went tumor resection three times for regional recurrence.
Eventually, right pneumonectomy had to be performed
due to three recurrent enormous tumors. The results in
our series also manifested that the rarity of PHs really had
the tendency of malignance.
Because the symptoms of patients with PH were fre-
quently indistinguishable from those of a carcinoma,
radiological examination was necessary for diagnosis of
PH. The PHs tended to be small (less than 4 cm), round,
peripheral, well-circumscribed tumors that occasionally
showed "popcorn" calcifications on chest radiograph.
They were usually asymptomatic and discovered inciden-
tally in radiologic studies [30]. All of the hamartomas in
our series were representing as intrapulmonary mass
shadow without pleural indentation sign, sublobe or sen-
tus. Calcifications were found in 15 cases and only 6 of
them were the typical popcorn calcification. As the charac-
teristic appearance on chest radiograph, popcorn calcifica-
tion was important for diagnosis of PH. However, it could
not be the definitive diagnostic evidence since calcifica-
tions may appear in carcinomas and in tuberculosis as
well. It was also observed that the lesions of some cases
displayed with solitary nodules, which could not be dif-
ferentiated from lung cancer before operation (shown in
figure 1).
Aspirates of PH were often scanty because of the dense
nature of the lesion. And the diagnostic accuracy has been
shown to be less for PH than for malignant tumors, partly
because of the difficulty in obtaining diagnostic material
from cartilaginous lesions and partly because of difficulty
in the interpretation of the findings [30-33]. Considering
the risk of pneumothorax and the potential delaying of
possible malignant lesion, and because all patients in our
series had the indications of surgery, aspirates was not per-
formed in our study.
Today, even with the advancement in medical therapy,
pulmonary resection remains the most important treat
measure of patients with PH. Controversy, however, still
exists about the indication and timing of surgery [10-12].
Since most PHs are nonexpanding or slowly growing neo-Page 3 of 5
(page number not for citation purposes)
Journal of Experimental & Clinical Cancer Research 2008, 27:8 http://www.jeccr.com/content/27/1/8plasms, some authors believed that surgery was necessary
only when expansion was recorded in young or middle-
aged patients or accompanying obvious pulmonary symp-
toms. In our opinion, the PH did have the tendency of
expansion or recurrence, and chronic inflammatory stim-
ulation of local position might contribute to the develop-
ment of malignancy. Therefore, when a solitary
pulmonary lesion was more than 2.5 cm or the possibility
of malignancy could not be excluded, surgical resection
was deserved to be performed and should be mandatory.
In terms of indications of surgery, the author presumed to
conclude as follows: (1) a solitary pulmonary lesion with
diameter more than 2.5 cm; (2) overweight psychic bur-
den making it necessary to remove the lesion; (3) having
the tendency of expansion or recurrence; (4) with pulmo-
nary symptoms unresponsive to drug treatment; (5)
above all, the lesion could not be differentiated from
malignancy. Especially to the patients in the fifth section,
any unwiring delay would minimize their chances of
acquiring long-term survival.
Conclusion
Wedge resection was the main choice in our series for
patients with PH. More aggressive lobectomy or total
pneumonectomy was considered only in such status: (1)
the central intrapulmonary hamartoma located in the
deep part of pulmonary lobes and adhered severely to
hilum of the lung, (2) the distal lung tissue was nonfunc-
tional, (3) multiple or huge tumors making wedge resec-
tion impossible. To avoid ignoring potential malignant
lesions, the necessity of the intraoperative frozen section
must be emphasized. Regarding the principles of the sur-
gery, we believed that normal lung tissue should be
reserved as much as possible. Furthermore, due to lack of
the malignance after operation in our series, the author
presumed that the wedge resection was safe enough. How-
ever, due to the potential trend of recurrence, it must be
emphasized that the patients with PH should be submit-
ted to a complete evaluation and regular follow-up.
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